SARS (Severe Acute Respiratory Syndrome) Clinical Trial
Official title:
Automated Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure
NCT number | NCT04374734 |
Other study ID # | 7791 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 5, 2020 |
Est. completion date | June 30, 2020 |
Verified date | April 2020 |
Source | University Hospital, Strasbourg, France |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Acute respiratory failure (ARF) is a common condition and a common reason for urgent medical consultation. Assessing the extent of respiratory impairment is important to improve the management of patients with ARF. When Acute respiratory failure is caused by pathology of the pulmonary parenchyma, quantification of pulmonary radiographic involvement may be a component of the initial assessment of severity. This radiographic quantification would only be usable in clinical routine if it can be automated and provide a real-time result. The objective of this work is to assess the feasibility of an automated technique for quantifying radiological lung damage in situations of known or potential ARF.
Status | Completed |
Enrollment | 100 |
Est. completion date | June 30, 2020 |
Est. primary completion date | June 30, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients over 18 years of age - Presenting a situation at risk of acute respiratory failure - Requiring thorax imaging when they were treated. Exclusion Criteria: - Patients with anatomically incomplete thoracic imaging (e.g., technical acquisition error). |
Country | Name | City | State |
---|---|---|---|
France | Service d' Anesthésie Réanimation Chirurgicale | Strasbourg |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Strasbourg, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Retrospective study of the relationship between severe forms of ARF and the extent of lung involvement | 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04615052 -
Home-based Exercise in COVID-19 Survivors
|
N/A | |
Completed |
NCT04720794 -
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
|
N/A | |
Enrolling by invitation |
NCT04659486 -
Adolescents With COVID-19/MIS-C at HCFMUSP
|
N/A | |
Completed |
NCT04784481 -
Ivermectin Reproposing for Mild Stage COVID-19 Outpatients
|
Phase 1/Phase 2 | |
Recruiting |
NCT04584658 -
Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
|
||
Active, not recruiting |
NCT04558476 -
Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation
|
Phase 2 | |
Withdrawn |
NCT04456426 -
Characteristics of Patients With COVID-19 in Meta State, Colombia
|
||
Completed |
NCT04546581 -
Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
|
Phase 3 | |
Completed |
NCT04446429 -
Anti-Androgen Treatment for COVID-19
|
N/A | |
Completed |
NCT04701710 -
Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT05054075 -
Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19
|
Phase 2 | |
Withdrawn |
NCT04590274 -
Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
|
Phase 1 | |
Completed |
NCT04644159 -
Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]
|
||
Recruiting |
NCT04978025 -
Colloidal Silver, Treatment of COVID-19
|
N/A | |
Enrolling by invitation |
NCT04540185 -
A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19
|
Phase 3 | |
Recruiting |
NCT04497454 -
Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19)
|
N/A | |
Completed |
NCT04366908 -
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT04390412 -
Low Dose Radiotherapy in COVID-19 Pneumonia
|
Phase 1/Phase 2 | |
Terminated |
NCT04382391 -
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms
|
N/A | |
Recruiting |
NCT04560257 -
High Flow Nasal Cannula HFNC In Covid-19 Patients
|
N/A |